118 related articles for article (PubMed ID: 3321740)
1. [Dose-response study with O-(beta-hydroxyethyl)-rutoside oral solution].
Nocker W; Diebschlag W
Vasa; 1987; 16(4):365-9. PubMed ID: 3321740
[No Abstract] [Full Text] [Related]
2. [A 3-month, randomized double-blind dose-response study with 0-(beta-hydroxyethyl)-rutoside oral solutions].
Nocker W; Diebschlag W; Lehmacher W
Vasa; 1989; 18(3):235-8. PubMed ID: 2678805
[TBL] [Abstract][Full Text] [Related]
3. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
Bergqvist D; Hallböök T; Lindblad B; Lindhagen A
Vasa; 1981; 10(3):253-60. PubMed ID: 7025500
[No Abstract] [Full Text] [Related]
4. [Modifications induced by long-term treatment with high doses of 0-(beta-hydroxyethyl)-rutoside in chronic venous insufficiency].
Barbarino C; Pezzangora V
Vasa Suppl; 1989; 27():120. PubMed ID: 2623482
[No Abstract] [Full Text] [Related]
5. A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers.
Mann RJ
Br J Clin Pract; 1981 Feb; 35(2):79-81. PubMed ID: 7020736
[No Abstract] [Full Text] [Related]
6. Study of the activity of a flavonoid, 3-(beta-hydroxyethyl)-rutoside, at high dose levels on venous tone measured by "strain gauge" plethylsmography.
Forconi S; Guerrini M; Di Perri T
Vasa; 1977; 6(3):279-84. PubMed ID: 335696
[No Abstract] [Full Text] [Related]
7. [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study].
Artaria LG
Klin Monbl Augenheilkd; 1982 Jun; 180(6):568-70. PubMed ID: 6752553
[No Abstract] [Full Text] [Related]
8. Paroven in the treatment of chronic venous insufficiency.
Pulvertaft TB
Practitioner; 1979 Dec; 223(1338):838-41. PubMed ID: 396527
[No Abstract] [Full Text] [Related]
9. [Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency].
Stemmer R; Furderer CR
Phlebologie; 1986; 39(4):995-1003. PubMed ID: 3562569
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of acute symptoms of hemorrhoid disease with high-dose oral O-(beta-hydroxyethyl)-rutosides].
Annoni F; Boccasanta P; Chiurazzi D; Mozzi E; Oberhauser V
Minerva Med; 1986 Sep; 77(37):1663-8. PubMed ID: 3531924
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
[TBL] [Abstract][Full Text] [Related]
12. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK.
Pulvertaft TB
Vasa; 1983; 12(4):373-6. PubMed ID: 6362258
[No Abstract] [Full Text] [Related]
13. [Critical study of the therapeutic effects of phlebotropic drugs on chronic venous insufficiency].
Roztocil K; Prerovsky I; Oliva I
Phlebologie; 1979; 32(4):395-8. PubMed ID: 120945
[TBL] [Abstract][Full Text] [Related]
14. [Clinical, placebo-controlled double-blind study of venoruton in the treatment of chronic venous insufficiency. Importance of the selection of patients].
Balmer A; Limoni C
Vasa; 1980; 9(1):76-82. PubMed ID: 7368843
[No Abstract] [Full Text] [Related]
15. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
Pedersen FM; Hamberg O; Sørensen MD; Neland K
Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
[TBL] [Abstract][Full Text] [Related]
16. [Benzopyrone in the therapy of postreconstructive edema. A clinical double-blind study].
Becker HM; Niedermaier G; Orend KH
Fortschr Med; 1985 Jun; 103(21):593-6. PubMed ID: 4018687
[No Abstract] [Full Text] [Related]
17. [Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside].
Agolini G; Cavallini GM
Clin Ter; 1987 Jan; 120(2):101-10. PubMed ID: 2972438
[No Abstract] [Full Text] [Related]
18. Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
Hackett AM; Griffiths LA; Luyckx AS; van Cauwenberge H
Arzneimittelforschung; 1976; 26(5):925-8. PubMed ID: 989368
[TBL] [Abstract][Full Text] [Related]
19. Effect of HR (O-(beta-hydroxyethyl)-rutosides) on the impaired venous function of young females taking oral contraceptives. A strain gauge plethysmographic and clinical open controlled study.
Forconi S; Guerrini M; Pecchi S; Cappelli R; Bruni F
Vasa; 1980; 9(4):324-30. PubMed ID: 7008418
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
Piller NB; Morgan RG; Casley-Smith JR
Br J Plast Surg; 1988 Jan; 41(1):20-7. PubMed ID: 3278764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
